Analysis on the World's Specialty Pharmaceuticals Market, 2019 to 2026, Featuring Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group, and Recordati PharmaceuticalsHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Analysis on the World's Specialty Pharmaceuticals Market, 2019 to 2026, Featuring Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group, and Recordati PharmaceuticalsGlobeNewswireJanuary 2, 2020ReblogShareTweetShareDublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Specialty Pharmaceuticals Market, by Country (US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis" report has been added to ResearchAndMarkets.com's offering.The Global Specialty Pharmaceuticals Market is expected to be worth USD 568 Billion by 2026.Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. Specialty Pharmaceuticals considered to be more targeted drugs than traditional drugs and are also less toxic. Specialty pharmaceutical consists of products like blood-derived, biopharmaceuticals, and complex molecules. Specialty pharmaceuticals are high cost and complex drugs; the average price per patient per year for specialty medical therapy is about $35,000 to $75,000. Specialty pharmaceutical is used to treat rare diseases such as Hepatitis C, Cancer, Rheumatoid Arthritis, AIDS (Acquired Immunodeficiency Virus Syndrome), Crohn's disease, etc. Specialty pharmacy is multiplying and becoming a significant factor for health systems and producers across the United States. The FDA approved 21 new molecular entities in the second half of 2018. Out of these products, 12 (57%) are regarded as pharmaceutical specialties based on variables such as indication and designed use population, administrative and tracking considerations, price and/or restricted delivery procedures. In the last five years, the United States spending on specialty drugs has almost doubled.Oncology, Autoimmune, and Immunology are among the most significant application of global specialty pharmaceutical marketThe report studies the market for the following application segments: Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis, and Others. Due to the rising cases of oncology globally, Oncology is the leading application segment in this market place.Specialty Pharmaceutical Market Share is expected to cross half of the global pharmaceutical marketThe global pharmaceutical market is segmented by two types: traditional pharmaceutical and specialty pharmaceutical. At present, traditional pharmaceutical is in the dominating position across the globe, but due to increasing demands of specialty pharmaceutical products, it is anticipated that specialty pharmaceuticals will lead during the forecast period.Company AnalysisTeva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals are some of the companies that deal efficiently in the specialty pharmaceuticals business. These companies have been studied thoroughly in the report.Key Topics Covered 1. Introduction2. Research & Methodology3. Executive Summary4. Global Specialty Pharmaceuticals4.1 Market4.2 Specialty Drug Pipeline5. Market Share - Specialty Pharmaceutical Analysis5.1 By Country5.2 By Pharmaceutical Industry5.3 By Application6. Global Pharmaceuticals Analysis6.1 Total Market6.2 Traditional Pharmaceutical Market7. Country - Specialty Pharmaceutical7.1 United States7.1.1 Market7.1.2 Specialty Drug Pipeline7.2 Top 5 European Country7.3 United Kingdom7.4 France7.5 Germany7.6 Italy7.7 Spain7.8 Japan7.9 South Korea8. Application - Specialty Pharmaceutical Market8.1 Oncology8.2 Autoimmune8.3 Immunology8.4 HIV8.5 Multiple Sclerosis (MS)8.6 Viral Hepatitis8.7 Blood Coagulation8.8 Respiratory8.9 Osteoporosis8.10 All Others9. Market Dynamics9.1 Growth Drivers9.1.1 Improving Life Expectancy9.1.2 Surge in Spending on Medicines9.1.3 Prevalence of Chronic Disease9.2 Key Challenges9.2.1 Abandonment Rates for Specialty Medicines & High R&D Costs10. Trend and Opportunities10.1 Trends10.1.1 Increased Spending on Specialty Pharmacy10.1.2 A Generic Wave of Specialty Drugs10.1.3 An Ever-expanding Pipeline of Products10.1.4 Targeted Therapies to Emerge10.1.5 Healthcare Reforms to Take Control10.1.6 Growth of Co-Pay Programs10.1.7 Medication Therapy Management (MTM) will Advance10.1.8 Specialty Prescribing to Rise10.1.9 Real-Time Pharmacy Benefit10.2 Opportunities10.2.1 Leverage the Changing Face of Specialty Pharmacy Industry with Flat world Solutions11. Specialty Pharmacy Mergers and Acquisitions12. Company Analysis12.1 Teva Pharmaceutical Industries Ltd.12.1.1 Overview12.1.2 Recent Developments12.1.3 Revenue12.2 CVS Health12.3 Endo International Specialty Products12.4 UnitedHealth Group Incorporated12.5 Recordati Pharmaceuticals Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/6ujrveStory continuesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextLatin America roundup: SoftBank adds $1B, Stori raises $10M and Grow Mobility puts on the brakesTechCrunchDicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue EstimatesZacks4 Giants See Stocks Plummet on Coronavirus WarningsGuruFocus.comTrade Desk Tops Earnings Views, Sets Higher Investments In Internet TVInvestor's Business DailyWalmart’s Answer to Amazon Prime? Walmart+Footwear NewsRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo Finance